DK127332B - Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner. - Google Patents
Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner.Info
- Publication number
- DK127332B DK127332B DK603267A DK603267A DK127332B DK 127332 B DK127332 B DK 127332B DK 603267 A DK603267 A DK 603267A DK 603267 A DK603267 A DK 603267A DK 127332 B DK127332 B DK 127332B
- Authority
- DK
- Denmark
- Prior art keywords
- quinazolinones
- substituted
- preparation
- therapeutically effective
- analogous process
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
- C07D239/82—Oxygen atoms with an aryl radical attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
- C07D239/80—Oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR85985A FR6001M (xx) | 1966-12-02 | 1966-12-02 | |
FR97203A FR1520743A (fr) | 1966-12-02 | 1967-03-02 | Nouvelles quinazolinones substituées et procédé de préparation |
FR106810A FR6158M (xx) | 1966-12-02 | 1967-05-18 | |
FR125422 | 1967-10-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK127332B true DK127332B (da) | 1973-10-22 |
Family
ID=27444746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK603267A DK127332B (da) | 1966-12-02 | 1967-12-01 | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner. |
Country Status (7)
Country | Link |
---|---|
CH (1) | CH482685A (xx) |
DE (1) | DE1695656B2 (xx) |
DK (1) | DK127332B (xx) |
FR (3) | FR6001M (xx) |
GB (1) | GB1181570A (xx) |
IL (1) | IL28991A (xx) |
NL (1) | NL6716429A (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3923803A (en) * | 1968-07-18 | 1975-12-02 | Sumitomo Chemical Co | 2(1H)-Quinozalinones and process therefor |
DE1932402C3 (de) * | 1969-06-26 | 1981-09-03 | Sandoz-Patent-GmbH, 7850 Lörrach | 1-Isopropyl-4-phenyl-3,4-dihydro-2(1H)chinazolinonderivate und deren Weiterverarbeitung zu 1-Isopropyl-4-phenyl-2(1H)chinazolinonen |
DE2118315C3 (de) * | 1970-04-20 | 1975-04-03 | Sumitomo Chemical Co., Ltd., Osaka (Japan) | 2-(1H)-Chinazolinonderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
US3764600A (en) * | 1970-10-06 | 1973-10-09 | Sandoz Ag | 1-substituted-quinazoline-2(1h)-thiones |
US3925549A (en) * | 1970-10-06 | 1975-12-09 | Sandoz Ag | 1-Substituted-quinazoline-2(1H)-thiones in the treatment of inflammation |
US4071516A (en) | 1976-08-20 | 1978-01-31 | Sandoz, Inc. | 4-(Acyloxyphenyl)-quinazolin-2(1H)-ones |
AR038658A1 (es) * | 2001-06-15 | 2005-01-26 | Novartis Ag | Derivados de 4-aril-2(1h) quinazolinona y 4-aril-quinazolina 2-sustituidas, un proceso para su preparacion, composiciones farmaceuticas y el uso de dichos derivados para la preparacion de un medicamento |
GB0230015D0 (en) | 2002-12-23 | 2003-01-29 | Novartis Ag | Organic compounds |
KR101781922B1 (ko) * | 2012-04-10 | 2017-09-26 | 안지 파마슈티컬 코퍼레이션 리미티드 | 히스톤 탈아세틸효소(hdacs) 억제제 |
-
1966
- 1966-12-02 FR FR85985A patent/FR6001M/fr not_active Expired
-
1967
- 1967-03-02 FR FR97203A patent/FR1520743A/fr not_active Expired
- 1967-05-18 FR FR106810A patent/FR6158M/fr not_active Expired
- 1967-11-21 IL IL2899167A patent/IL28991A/xx unknown
- 1967-11-23 CH CH1645167A patent/CH482685A/fr not_active IP Right Cessation
- 1967-12-01 DK DK603267A patent/DK127332B/da not_active IP Right Cessation
- 1967-12-01 NL NL6716429A patent/NL6716429A/xx unknown
- 1967-12-01 DE DE1967R0047487 patent/DE1695656B2/de active Granted
- 1967-12-04 GB GB55090/67A patent/GB1181570A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR1520743A (fr) | 1968-04-12 |
DE1695656B2 (de) | 1974-06-06 |
FR6001M (xx) | 1968-04-29 |
CH482685A (fr) | 1969-12-15 |
FR6158M (xx) | 1968-07-01 |
DE1695656A1 (de) | 1972-04-13 |
IL28991A (en) | 1972-11-28 |
NL6716429A (xx) | 1968-06-04 |
DE1695656C3 (xx) | 1979-12-06 |
GB1181570A (en) | 1970-02-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK128318B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive bischromoner. | |
FI48590C (fi) | Menetelmä terapeuttisesti käytettävien atsaspiroalkaanidioniyhdisteide n valmistamiseksi. | |
DK137854B (da) | Analogifremgangsmåde til fremstilling af 2-nitroimidazolderivater. | |
FI45970C (fi) | Menetelmä terapeuttisesti arvokkaiden 1-substituoitu-2-aryyli-4- tai 5 -nitroimidatsolien valmistamiseksi. | |
DK113645B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme indolyl-3-alkan-carboxylsyrer. | |
DK127332B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 1-substituerede 2[1H]-quinazolinoner. | |
DK115400B (da) | Fremgangsmåde til fremstilling af terapeutisk virksomme 3-keto-19-alkyl-androstaner. | |
FI47986C (fi) | Menetelmä terapeuttisesti aktiivisten 2,3-dihydro-1H-1,4-bentsodiatsep iini-2-onien valmistamiseksi | |
DK121708B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 22-aza-cholestanderivater. | |
FI45041C (fi) | Menetelmä terapeuttisesti käyttökelpoisten pyrroli-johdannaisten valmi stamiseksi. | |
DK130115B (da) | Analogifremgangsmåde til fremstilling af 1-substituerede 2(1H)-quinazolinoner. | |
DK117635B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3-(piperazinoalkyl)-pyrazoler. | |
DK131429B (da) | Analogifremgangsmåde til fremstilling af derivater af 4'-demethyl-epipodophyllotoxin-beta-D-glucosid. | |
DK122760B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 4-alkoxy-3,5-dimethoxybenzamider. | |
DK120399B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme phenylalaninderivater. | |
DK125891B (da) | Analogifremgangsmåde til fremstilling af nitroimidazoler. | |
FI47092C (fi) | Menetelmä terapeuttisesti arvokkaiden sekasubstituoitujen 1-fenoksi-3- alkyyliaminopropanolien-(2) valmistamiseksi. | |
FI47358C (fi) | Menetelmä terapeuttisesti käytettävän 4'-demetyyli-epipodofyllotoksiin i-beta-D-glukosidin valmistamiseksi. | |
FI46966C (fi) | Menetelmä terapeuttisesti käytettävien 1,3-dihydro-3-hydroksi-1,4-bent sodiatsepiini-2-onien valmistamiseksi | |
DK117488C (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 2α-3α-epithio-5α-androstaner. | |
DK116658B (da) | Fremgangsmåde til fremstilling af terapeutisk aktive 7α-methyl-Δ<5>-østrener. | |
DK103778C (da) | Fremgangsmåde til fremstilling af 1-substituerede cycloheptimidazol-2-(1H)-on-forbindelser. | |
DK122223B (da) | Analogifremgangsmåde til fremstilling af terapeutisk aktive biphenylforbindelser. | |
DK120845B (da) | Fremgangsmåde til fremstilling af 3β-formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enolider. | |
DK114203B (da) | Analogifremgangsmåde til fremstilling af terapeutisk virksomme 3,3-alkylendithio-13β-ethylgon-4-ener. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PBP | Patent lapsed |